I think you are right, On top of producing our own drugs the other part of our business will be to help others be more successful in producing their own drugs with our LM tech. Lower cost of production and better efficacy for companies partnering with us. I think the line for deal making could be very long in this healthcare environment.
What also probably stoked their interest is our outstanding safety profile.....and if they get some efficacy out of the combo it's a win-win situation. I think we're gonna see heaps more licence agreements to combo up. The flood gates will probably open wide after EU commercialization, imo.
Agree. There are plenty of companies like Sellas developing antigens. but you need a delivery system to really make the antigen work. ADXS Lm technology is the chosen delivery system. This is really exciting since we can replicate this deal with numerous partners, and largely let them pay to get the products approved. Very smart deal, the deal lady hired earned her bonus.
News 
Market Data 
Discover 
